The clinical outcome in AChR-positive generalized myasthenia gravis: A retrospective observational study

Background: Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, and in over 80% of cases, antibodies are identified against the nicotinic type of acetylcholine receptor (AChR) on the muscle endplate. Despite the availability of various treatment options, patients wi...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Pawan T Ojha, Abhijeet M Gaikwad, Rakesh Singh, Kamlesh Jagiasi, Shashank Nagendra
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wolters Kluwer Medknow Publications 2023-01-01
Sarja:	Annals of Indian Academy of Neurology
Aiheet:	achr positive myasthenia gravis (mg) rituximab treatment refractory
Linkit:	http://www.annalsofian.org/article.asp?issn=0972-2327;year=2023;volume=26;issue=4;spage=395;epage=400;aulast=Ojha
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!